The Secretary of Health (SOH) acknowledges the final recommendation of the HTA Council on reteplase (10 units lyophilized powder for IV injection) for ST-Elevation Myocardial Infarction (STEMI) patients  (date of receipt of acknowledgment: 02 January 2025). As a final recommendation, the HTA Council does not recommend the government financing of reteplase for STEMI patients.

For further details, please refer to the documents below: